Agoracom: Small Cap Investment - Mannkind - Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Reply New Message

Back To Forum List View

Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

brentie98

Mar 27, 2013 09:41AM

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

brentie98

Mar 27, 2013 11:19AM

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

brentie98

Mar 27, 2013 01:22PM

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

liahall

Mar 27, 2013 02:02PM

cannon5974

Rank: Mail Room [?]

Points: 44 [?]

Votes: 2 Score: 2.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

in response to

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

liahall

posted on Mar 27, 2013 02:33PM

Yes, I agree. With 2.5B in annual Revenue; the stock price should easily be between $15-$20/share, which would put the market cap between $6-$8B.

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

swingtrader88

Mar 27, 2013 04:00PM

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN